Skip to main content

Table 2 Clinical characteristics of bPOI patients and control patients for verification

From: Identification of transcriptome characteristics of granulosa cells and the possible role of UBE2C in the pathogenesis of premature ovarian insufficiency

Variable

bPOI (n = 12)

CON (n = 12)

P

Age(years)

32.00 ± 2.37

31.58 ± 2.43

0.675*

BMI (kg/m2)

21.80 ± 2.52

20.98 ± 1.70

0.362*

Basal FSH (IU/L)

15.84 ± 4.42

6.23 ± 1.07

 < 0.001*

Basal LH (IU/L)

4.76 ± 1.97

4.77 ± 2.23

0.996*

AMH (ng/ml)

0.55(0.20,0.96)

2.98(2.18,6.58)

 < 0.001#

Basal E2 (pg/ml)

33.78(11.80,95.00)

40.15(23.83,96.98)

0.266#

Bilateral AFC

4.92 ± 2.28

14.42 ± 3.18

 < 0.001*

Number of follicles over 14 mm on HCG day

3.00(1.00,6.00)

11.00(6.00,11.00)

 < 0.001#

Number of oocytes obtained

2.917 ± 1.240

12.917 ± 3.777

 < 0.001*

  1. Data are presented as mean ± SEM or median (interquartile range (IQR)) based on distribution
  2. bPOI Biochemical premature ovarian insufficiency, BMI Body mass index, FSH Follicle-stimulating hormone, LH Luteinizing hormone, AMH Anti-Mullerian hormone, E2 Estradiol; AFC Antral follicle counts, HCG Human chorionic gonadotropin
  3. *Student’s t-test
  4. #Mann–Whitney U-test